APO Research
Talk to an analyst

APO RESEARCH · REPORT

Daptomycin

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Daptomycin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025194 pages

Choose your research edition.

Industry ResearchDaptomycin Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Daptomycin Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Daptomycin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Daptomycin Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Daptomycin Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Daptomycin market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Daptomycin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Daptomycin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Daptomycin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Daptomycin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Daptomycin include HENGRUI PHARMA, Hisun, Sagent Pharmaceuticals, Xellia, Fresenius Kabi, Huadong Medicine, Pfizer, Mylan and Merck & Co., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Daptomycin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Daptomycin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Daptomycin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Daptomycin market size, projected growth trends, production technologies, key applications, and end-use industries.

Daptomycin Segment by Company

HENGRUI PHARMA

Hisun

Sagent Pharmaceuticals

Xellia

Fresenius Kabi

Huadong Medicine

Pfizer

Mylan

Merck & Co.

Teva

Daptomycin Segment by Type

350 mg Lyophilized Powder

500 mg Lyophilized Powder

Daptomycin Segment by Application

Adult

Pediatric Patients (1 to 17 years of age)

Daptomycin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Daptomycin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Daptomycin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Daptomycin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Daptomycin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Daptomycin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Daptomycin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Daptomycin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Daptomycin Industry Trends Table 2. Daptomycin Industry Drivers Table 3. Daptomycin Industry Opportunities and Challenges Table 4. Daptomycin Industry Restraints Table 5. Global Daptomycin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Daptomycin Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Daptomycin Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Daptomycin Sales Market Share by Manufacturers Table 9. Global Daptomycin Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Daptomycin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Daptomycin Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Daptomycin Manufacturers, Product Type & Application Table 13. Global Daptomycin Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Daptomycin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 350 mg Lyophilized Powder Table 17. Major Manufacturers of 500 mg Lyophilized Powder Table 18. Global Daptomycin Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 19. Global Daptomycin Sales by Type (2021-2026) & (W Units) Table 20. Global Daptomycin Sales by Type (2027-2032) & (W Units) Table 21. Global Daptomycin Sales Market Share by Type (2021-2026) Table 22. Global Daptomycin Sales Market Share by Type (2027-2032) Table 23. Global Daptomycin Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 24. Global Daptomycin Revenue by Type (2021-2026) & (W Units) Table 25. Global Daptomycin Revenue by Type (2027-2032) & (W Units) Table 26. Global Daptomycin Revenue Market Share by Type (2021-2026) Table 27. Global Daptomycin Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Adult Table 29. Major Manufacturers of Pediatric Patients (1 to 17 years of age) Table 30. Global Daptomycin Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 31. Global Daptomycin Sales by Application (2021-2026) & (W Units) Table 32. Global Daptomycin Sales by Application (2027-2032) & (W Units) Table 33. Global Daptomycin Sales Market Share by Application (2021-2026) Table 34. Global Daptomycin Sales Market Share by Application (2027-2032) Table 35. Global Daptomycin Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 36. Global Daptomycin Revenue by Application (2021-2026) & (W Units) Table 37. Global Daptomycin Revenue by Application (2027-2032) & (W Units) Table 38. Global Daptomycin Revenue Market Share by Application (2021-2026) Table 39. Global Daptomycin Revenue Market Share by Application (2027-2032) Table 40. Global Daptomycin Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 41. Global Daptomycin Sales by Region (2021-2026) & (W Units) Table 42. Global Daptomycin Sales Market Share by Region (2021-2026) Table 43. Global Daptomycin Sales Forecasted by Region (2027-2032) & (W Units) Table 44. Global Daptomycin Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Daptomycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 46. North America Daptomycin Sales by Country (2021-2026) & (W Units) Table 47. North America Daptomycin Sales by Country (2027-2032) & (W Units) Table 48. Europe Daptomycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 49. Europe Daptomycin Sales by Country (2021-2026) & (W Units) Table 50. Europe Daptomycin Sales by Country (2027-2032) & (W Units) Table 51. Asia Pacific Daptomycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 52. Asia Pacific Daptomycin Sales by Country (2021-2026) & (W Units) Table 53. Asia Pacific Daptomycin Sales by Country (2027-2032) & (W Units) Table 54. South America, Middle East and Africa Daptomycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 55. South America, Middle East and Africa Daptomycin Sales by Country (2021-2026) & (W Units) Table 56. South America, Middle East and Africa Daptomycin Sales by Country (2027-2032) & (W Units) Table 57. Global Daptomycin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Daptomycin Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Daptomycin Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Daptomycin Revenue Market Share by Region (2021-2026) Table 61. Global Daptomycin Revenue Market Share by Region (2027-2032) Table 62. HENGRUI PHARMA Company Information Table 63. HENGRUI PHARMA Business Overview Table 64. HENGRUI PHARMA Daptomycin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. HENGRUI PHARMA Daptomycin Product Portfolio Table 66. HENGRUI PHARMA Recent Development Table 67. Hisun Company Information Table 68. Hisun Business Overview Table 69. Hisun Daptomycin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Hisun Daptomycin Product Portfolio Table 71. Hisun Recent Development Table 72. Sagent Pharmaceuticals Company Information Table 73. Sagent Pharmaceuticals Business Overview Table 74. Sagent Pharmaceuticals Daptomycin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Sagent Pharmaceuticals Daptomycin Product Portfolio Table 76. Sagent Pharmaceuticals Recent Development Table 77. Xellia Company Information Table 78. Xellia Business Overview Table 79. Xellia Daptomycin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Xellia Daptomycin Product Portfolio Table 81. Xellia Recent Development Table 82. Fresenius Kabi Company Information Table 83. Fresenius Kabi Business Overview Table 84. Fresenius Kabi Daptomycin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Fresenius Kabi Daptomycin Product Portfolio Table 86. Fresenius Kabi Recent Development Table 87. Huadong Medicine Company Information Table 88. Huadong Medicine Business Overview Table 89. Huadong Medicine Daptomycin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Huadong Medicine Daptomycin Product Portfolio Table 91. Huadong Medicine Recent Development Table 92. Pfizer Company Information Table 93. Pfizer Business Overview Table 94. Pfizer Daptomycin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Pfizer Daptomycin Product Portfolio Table 96. Pfizer Recent Development Table 97. Mylan Company Information Table 98. Mylan Business Overview Table 99. Mylan Daptomycin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Mylan Daptomycin Product Portfolio Table 101. Mylan Recent Development Table 102. Merck & Co. Company Information Table 103. Merck & Co. Business Overview Table 104. Merck & Co. Daptomycin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Merck & Co. Daptomycin Product Portfolio Table 106. Merck & Co. Recent Development Table 107. Teva Company Information Table 108. Teva Business Overview Table 109. Teva Daptomycin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Teva Daptomycin Product Portfolio Table 111. Teva Recent Development Table 112. Key Raw Materials Table 113. Raw Materials Key Suppliers Table 114. Daptomycin Distributors List Table 115. Daptomycin Customers List Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Daptomycin Product Image Figure 2. Global Daptomycin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Daptomycin Market Size (2021-2032) & (US$ Million) Figure 4. Global Daptomycin Sales (2021-2032) & (W Units) Figure 5. Global Daptomycin Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Daptomycin Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 350 mg Lyophilized Powder Image Figure 9. 500 mg Lyophilized Powder Image Figure 10. Global Daptomycin Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 11. Global Daptomycin Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Daptomycin Sales Market Share by Type (2021-2032) Figure 13. Global Daptomycin Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global Daptomycin Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Daptomycin Revenue Market Share by Type (2021-2032) Figure 16. Adult Image Figure 17. Pediatric Patients (1 to 17 years of age) Image Figure 18. Global Daptomycin Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 19. Global Daptomycin Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Daptomycin Sales Market Share by Application (2021-2032) Figure 21. Global Daptomycin Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 22. Global Daptomycin Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Daptomycin Revenue Market Share by Application (2021-2032) Figure 24. North America Daptomycin Sales and Growth Rate (2021-2032) & (W Units) Figure 25. North America Daptomycin Sales Market Share by Country (2021-2032) Figure 26. U.S. Daptomycin Sales and Growth Rate (2021-2032) & (W Units) Figure 27. Canada Daptomycin Sales and Growth Rate (2021-2032) & (W Units) Figure 28. Mexico Daptomycin Sales and Growth Rate (2021-2032) & (W Units) Figure 29. Europe Daptomycin Sales and Growth Rate (2021-2032) & (W Units) Figure 30. Europe Daptomycin Sales Market Share by Country (2021-2032) Figure 31. Germany Daptomycin Sales and Growth Rate (2021-2032) & (W Units) Figure 32. France Daptomycin Sales and Growth Rate (2021-2032) & (W Units) Figure 33. U.K. Daptomycin Sales and Growth Rate (2021-2032) & (W Units) Figure 34. Italy Daptomycin Sales and Growth Rate (2021-2032) & (W Units) Figure 35. Netherlands Daptomycin Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Asia Pacific Daptomycin Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Asia Pacific Daptomycin Sales Market Share by Country (2021-2032) Figure 38. China Daptomycin Sales and Growth Rate (2021-2032) & (W Units) Figure 39. Japan Daptomycin Sales and Growth Rate (2021-2032) & (W Units) Figure 40. South Korea Daptomycin Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Southeast Asia Daptomycin Sales and Growth Rate (2021-2032) & (W Units) Figure 42. India Daptomycin Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Australia Daptomycin Sales and Growth Rate (2021-2032) & (W Units) Figure 44. South America, Middle East and Africa Daptomycin Sales and Growth Rate (2021-2032) & (W Units) Figure 45. South America, Middle East and Africa Daptomycin Sales Market Share by Country (2021-2032) Figure 46. Brazil Daptomycin Sales and Growth Rate (2021-2032) & (W Units) Figure 47. South Africa Daptomycin Sales and Growth Rate (2021-2032) & (W Units) Figure 48. Saudi Arabia Daptomycin Sales and Growth Rate (2021-2032) & (W Units) Figure 49. Turkey Daptomycin Sales and Growth Rate (2021-2032) & (W Units) Figure 50. Argentina Daptomycin Sales and Growth Rate (2021-2032) & (W Units) Figure 51. UAE Daptomycin Sales and Growth Rate (2021-2032) & (W Units) Figure 52. Egypt Daptomycin Sales and Growth Rate (2021-2032) & (W Units) Figure 53. Chile Daptomycin Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Global Daptomycin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Daptomycin Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Daptomycin Revenue (2021-2032) & (US$ Million) Figure 57. North America Daptomycin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Daptomycin Revenue (2021-2032) & (US$ Million) Figure 59. Europe Daptomycin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Daptomycin Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Daptomycin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Daptomycin Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Daptomycin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Daptomycin Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Daptomycin Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 350 mg Lyophilized Powder
  • 500 mg Lyophilized Powder
Applications
  • Adult
  • Pediatric Patients (1 to 17 years of age)
Companies covered
  • HENGRUI PHARMA
  • Hisun
  • Sagent Pharmaceuticals
  • Xellia
  • Fresenius Kabi
  • Huadong Medicine
  • Pfizer
  • Mylan
  • Merck & Co.
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Daptomycin Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Daptomycin Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Daptomycin Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Daptomycin Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Daptomycin Market Dynamics
  1. 2.1 Daptomycin Industry Trends
  2. 2.2 Daptomycin Industry Drivers
  3. 2.3 Daptomycin Industry Opportunities and Challenges
  4. 2.4 Daptomycin Industry Restraints
3 Daptomycin Market by Manufacturers
  1. 3.1 Global Daptomycin Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Daptomycin Sales by Manufacturers (2021-2026)
  3. 3.3 Global Daptomycin Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Daptomycin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Daptomycin Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Daptomycin Manufacturers, Product Type & Application
  7. 3.7 Global Daptomycin Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Daptomycin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Daptomycin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Daptomycin Tier 1, Tier 2, and Tier 3
4 Daptomycin Market by Type
  1. 4.1 Daptomycin Type Introduction
  2. 4.1.1 350 mg Lyophilized Powder
  3. 4.1.2 500 mg Lyophilized Powder
  4. 4.2 Global Daptomycin Sales by Type
  5. 4.2.1 Global Daptomycin Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Daptomycin Sales by Type (2021-2032)
  7. 4.2.3 Global Daptomycin Sales Market Share by Type (2021-2032)
  8. 4.3 Global Daptomycin Revenue by Type
  9. 4.3.1 Global Daptomycin Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Daptomycin Revenue by Type (2021-2032)
  11. 4.3.3 Global Daptomycin Revenue Market Share by Type (2021-2032)
5 Daptomycin Market by Application
  1. 5.1 Daptomycin Application Introduction
  2. 5.1.1 Adult
  3. 5.1.2 Pediatric Patients (1 to 17 years of age)
  4. 5.2 Global Daptomycin Sales by Application
  5. 5.2.1 Global Daptomycin Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Daptomycin Sales by Application (2021-2032)
  7. 5.2.3 Global Daptomycin Sales Market Share by Application (2021-2032)
  8. 5.3 Global Daptomycin Revenue by Application
  9. 5.3.1 Global Daptomycin Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Daptomycin Revenue by Application (2021-2032)
  11. 5.3.3 Global Daptomycin Revenue Market Share by Application (2021-2032)
6 Global Daptomycin Sales by Region
  1. 6.1 Global Daptomycin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Daptomycin Sales by Region (2021-2032)
  3. 6.2.1 Global Daptomycin Sales by Region (2021-2026)
  4. 6.2.2 Global Daptomycin Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Daptomycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Daptomycin Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Daptomycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Daptomycin Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Daptomycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Daptomycin Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Daptomycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Daptomycin Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Daptomycin Revenue by Region
  1. 7.1 Global Daptomycin Revenue by Region
  2. 7.1.1 Global Daptomycin Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Daptomycin Revenue by Region (2021-2026)
  4. 7.1.3 Global Daptomycin Revenue by Region (2027-2032)
  5. 7.1.4 Global Daptomycin Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Daptomycin Revenue (2021-2032)
  8. 7.2.2 North America Daptomycin Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Daptomycin Revenue (2021-2032)
  11. 7.3.2 Europe Daptomycin Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Daptomycin Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Daptomycin Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Daptomycin Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Daptomycin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 HENGRUI PHARMA
  2. 8.1.1 HENGRUI PHARMA Company Information
  3. 8.1.2 HENGRUI PHARMA Business Overview
  4. 8.1.3 HENGRUI PHARMA Daptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 HENGRUI PHARMA Daptomycin Product Portfolio
  6. 8.1.5 HENGRUI PHARMA Recent Developments
  7. 8.2 Hisun
  8. 8.2.1 Hisun Company Information
  9. 8.2.2 Hisun Business Overview
  10. 8.2.3 Hisun Daptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Hisun Daptomycin Product Portfolio
  12. 8.2.5 Hisun Recent Developments
  13. 8.3 Sagent Pharmaceuticals
  14. 8.3.1 Sagent Pharmaceuticals Company Information
  15. 8.3.2 Sagent Pharmaceuticals Business Overview
  16. 8.3.3 Sagent Pharmaceuticals Daptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sagent Pharmaceuticals Daptomycin Product Portfolio
  18. 8.3.5 Sagent Pharmaceuticals Recent Developments
  19. 8.4 Xellia
  20. 8.4.1 Xellia Company Information
  21. 8.4.2 Xellia Business Overview
  22. 8.4.3 Xellia Daptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Xellia Daptomycin Product Portfolio
  24. 8.4.5 Xellia Recent Developments
  25. 8.5 Fresenius Kabi
  26. 8.5.1 Fresenius Kabi Company Information
  27. 8.5.2 Fresenius Kabi Business Overview
  28. 8.5.3 Fresenius Kabi Daptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Fresenius Kabi Daptomycin Product Portfolio
  30. 8.5.5 Fresenius Kabi Recent Developments
  31. 8.6 Huadong Medicine
  32. 8.6.1 Huadong Medicine Company Information
  33. 8.6.2 Huadong Medicine Business Overview
  34. 8.6.3 Huadong Medicine Daptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Huadong Medicine Daptomycin Product Portfolio
  36. 8.6.5 Huadong Medicine Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer Daptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Daptomycin Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 Mylan
  44. 8.8.1 Mylan Company Information
  45. 8.8.2 Mylan Business Overview
  46. 8.8.3 Mylan Daptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Mylan Daptomycin Product Portfolio
  48. 8.8.5 Mylan Recent Developments
  49. 8.9 Merck & Co.
  50. 8.9.1 Merck & Co. Company Information
  51. 8.9.2 Merck & Co. Business Overview
  52. 8.9.3 Merck & Co. Daptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Merck & Co. Daptomycin Product Portfolio
  54. 8.9.5 Merck & Co. Recent Developments
  55. 8.10 Teva
  56. 8.10.1 Teva Company Information
  57. 8.10.2 Teva Business Overview
  58. 8.10.3 Teva Daptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Teva Daptomycin Product Portfolio
  60. 8.10.5 Teva Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Daptomycin Value Chain Analysis
  2. 9.1.1 Daptomycin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Daptomycin Production Mode & Process
  6. 9.2 Daptomycin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Daptomycin Distributors
  9. 9.2.3 Daptomycin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst